{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:39Z","timestamp":1786119039285,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Drug Monitoring"],"published-print":{"date-parts":[[1986,3]]},"DOI":"10.1097\/00007691-198603000-00005","type":"journal-article","created":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T03:57:43Z","timestamp":1231214263000},"page":"23-26","source":"Crossref","is-referenced-by-count":3,"title":["Plasma Nor1-Chlorpromazine Concentrations"],"prefix":"10.1097","volume":"8","author":[{"given":"Robert C.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007691-198603000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:26:52Z","timestamp":1786037212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-198603000-00005"}},"subtitle":["Effects of Age, Race, and Sex"],"short-title":[],"issued":{"date-parts":[[1986,3]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1097\/00007691-198603000-00005","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[1986,3]]}}}